RESEARCH & DEVELOPMENT

 

RESEARCH & DEVELOPMENT

 
PHARMACEUTICAL

AntalGenics uses its more than 16 years of research experience to clinically develop novel therapeutic leads, mainly for the treatment of psoriatic pruritus and psoriatic comorbidities, such as arthritis.

COSMECEUTICAL

AntalGenics has extensive experience in the development of cosmetics. Our innovation in the design of compounds and the search for novel molecular mechanisms, has led to the commercialization of several products, demonstrating the high competitiveness of the scientific team in the cosmetic sector.

GET TO KNOW MORE

 
PHARMACEUTICAL

AntalGenics’ R&D programme focuses on the discovery and development of new molecules to treat chronic painful disorders. Our scientific team has a long-track experience in pain research and applies the most advanced technologies to identify new molecular targets and to understand the underlying disease’s molecular mechanisms.

With this knowledge, AntalGenics is currently developing two new molecular entities to provide precise innovative therapies for psoriatic pruritus and osteoarthritic pain.

COSMECEUTICAL

AntalGenics provides supplementary solutions in the field of dermatology. Our team has a proven track record of bringing new cosmeceutical products to market with the main goal to improve skin care by science.

AntalGenics has built a pipeline of innovative compounds to manage sensitive skin conditions by targeting neurogenic inflammation: AntalGenics is currently focusing its target compounds on mild atopia, dermatitis (contact, seborrheic, allegenic, stress, etc.) and rosacea.

ANTALGENICS OFFERS

 
Proven-track record in pain research
Specialists in ion channel research and neuronal exocytosis
Full access to University infrastructures
Skilled team in sensory biology
Rich-network of partner research groups
Experts in molecular modeling and in silico screening
A long standing experience in cosmeceutics